Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials - The Lancet
View of Management of lipids in adults with diabetes mellitus and nephropathy and/or chronic kidney disease: summary of joint guidance from the Association of British Clinical Diabetologists (ABCD) and the Renal Association (
Studie: Statine fördern Fortschreiten eines Typ-2-Diabetes
Proportion of patients with type 2 diabetes mellitus who received... | Download Table
Statin patterns and associated factors in type 2 diabetes | DMSO
Statin treatment and new-onset diabetes: A review of proposed mechanisms - ScienceDirect
Role of Irbesartan and Curcumin in type 2 Diabetes mellitus: An experimental study on rats using Amlodipine & Atorvastatin as standard drugs: Leve, Sharad, Verma, Rakesh, Dixit, Rakesh Kumar: 9783659348921: Amazon.com: Books
Typ-2-Diabetes: Höheres Progressionsrisiko unter Statin-Therapie?
Recent dyslipidemia guidelines for patients with diabetes mellitus
LDL Cholesterol and Diabetes | CRESTOR® (rosuvastatin calcium)
Senkung der kardiovaskulären Ereignisse mit Atorvastatin bei Patienten mit Typ-2-Diabetes
IJMS | Free Full-Text | Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights
Statintherapie erhöht Diabetesrisiko bei Hoch-Risiko-Gruppen
Statin treatment and new-onset diabetes: A review of proposed mechanisms - ScienceDirect
Atorvastatin bei Typ-2-Diabetikern - 05 - 2005 - Heftarchiv - AMT
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial - The Lancet
Association between statin treatment and new-onset diabetes mellitus: a population based case–control study | Diabetology & Metabolic Syndrome | Full Text
Statins & Diabetes: Everything You Need to Know - Diabetes Strong
Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study | Journal of the American Heart Association
Behandlungsoptionen bei Statin-assoziierten Muskelbeschwerden
Associations of statin use with glycaemic traits and incident type 2 diabetes
Statins Linked With Type 2 Diabetes Progression, Study Suggests | Everyday Health
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial - The Lancet
![PDF] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/76483f997fe0c7d9eea72efc792ccc924b3332de/6-Figure3-1.png "PDF] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial | Semantic Scholar")
PDF] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial | Semantic Scholar
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program | BMJ Open Diabetes Research & Care
Biomedicines | Free Full-Text | Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology
Vorsicht mit Statinen bei Typ-2-Diabetikern
Clinical and biochemical characteristics of type 2 diabetic patients... | Download Table
